HU, S., R, B., D, K., & K, C. (2015). Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies. British journal of clinical pharmacology, 79(6), 959. https://doi.org/10.1111/bcp.12571
Chicago Style (17th ed.) CitationHU, Siegmund, Burghaus R, Kubitza D, and Coboeken K. "Contribution of Rivaroxaban to the International Normalized Ratio When Switching to Warfarin for Anticoagulation as Determined by Simulation Studies." British Journal of Clinical Pharmacology 79, no. 6 (2015): 959. https://doi.org/10.1111/bcp.12571.
MLA (9th ed.) CitationHU, Siegmund, et al. "Contribution of Rivaroxaban to the International Normalized Ratio When Switching to Warfarin for Anticoagulation as Determined by Simulation Studies." British Journal of Clinical Pharmacology, vol. 79, no. 6, 2015, p. 959, https://doi.org/10.1111/bcp.12571.